A Study of AT-02 in Subjects With Systemic Amyloidosis.

Condition:   Amyloidosis; Systemic Intervention:   Drug: AT02 Sponsors:   Attralus, Inc.;   Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials